Tokyo – March 2025 – We are proud to announce that Dr. Taku Kambayashi, Co-Founder and Chief Science Advisor (CSA) of Abrax Japan, has been invited to speak at the Yale Innovation Summit 2025, held on May 28–29 at Yale University in New Haven, Connecticut.
The Yale Innovation Summit brings together global leaders in biotech, health, civic innovation, climate, technology, and the arts to share disruptive research and ideas that will shape the future.
Dr. Kambayashi will present Abrax Japan’s cutting-edge research on modulating systemic lipid metabolism through the stimulation of skin-derived factors. This innovative therapeutic approach aims to restore natural lipid homeostasis and enhance the skin barrier, with applications ranging from atopic dermatitis to broader metabolic disorders.
Abrax Japan is committed to pioneering skin-based therapeutics that heal from the outside in, leveraging the skin’s innate power to influence internal health. Our vision is to redefine medicine by positioning the skin as a gateway to systemic healing.
◆ Comment from CEO Jo Narita:
“It is a great honor for our science to be recognized on a prestigious global stage such as the Yale Innovation Summit. At Abrax Japan, we believe in the transformative potential of skin-initiated healing. We hope this opportunity will foster new international collaborations and accelerate our mission to develop novel, skin-powered medicines for the world.”
For more information and registration, please visit:
https://ventures.yale.edu/events/yale-innovation-summit-2025
For further inquiries, please contact us here.
